ANIP
ANI Pharmaceuticals Inc

1,134
Mkt Cap
$1.59B
Volume
517,923.00
52W High
$99.50
52W Low
$56.71
PE Ratio
21.03
ANIP Fundamentals
Price
$70.49
Prev Close
$72.49
Open
$72.62
50D MA
$79.02
Beta
0.63
Avg. Volume
329,315.37
EPS (Annual)
$3.32
P/B
2.93
Rev/Employee
$910,686.60
$2,009.27
Loading...
Loading...
News
all
press releases
Christopher Mutz Sells 3,162 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) Stock
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) insider Christopher Mutz sold 3,162 shares of the company's stock in a transaction that occurred on Friday, March 13th. The stock was sold at...
MarketBeat·10h ago
News Placeholder
More News
News Placeholder
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Rating Lowered by Wall Street Zen
Wall Street Zen cut ANI Pharmaceuticals from a "strong-buy" rating to a "buy" rating in a research report on Saturday...
MarketBeat·16h ago
News Placeholder
Meredith Cook Sells 500 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) Stock
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) VP Meredith Cook sold 500 shares of the firm's stock in a transaction on Friday, March 13th. The shares were sold at an average price of...
MarketBeat·21h ago
News Placeholder
Insider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) Insider Sells 3,162 Shares of Stock
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) insider Christopher Mutz sold 3,162 shares of the company's stock in a transaction dated Friday, March 13th. The shares were sold at an...
MarketBeat·21h ago
News Placeholder
ANI Pharmaceuticals (NASDAQ:ANIP) SVP Thomas Andrew Rowland Sells 4,772 Shares
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) SVP Thomas Andrew Rowland sold 4,772 shares of the stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an...
MarketBeat·21h ago
News Placeholder
4 Biotech Stocks to Watch for Potential Upside in 2026
New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position TERN, ADMA, ANIP and LQDA in this volatile sector.
Zacks·1d ago
News Placeholder
United Therapeutics Stock Surges 32% in 6 Months: Here's Why
UTHR shares jump 32% in six months as Tyvaso sales surge, earnings grow and Phase III TETON-2 data open a potential new market in IPF.
Zacks·1d ago
News Placeholder
Allogene Therapeutics Posts Narrower-Than-Expected Loss in Q4
ALLO posts a narrower Q4 loss than expected, cuts expenses and advances key CAR-T studies, with cash projected to fund operations into 2028.
Zacks·1d ago
News Placeholder
ANI Pharmaceuticals, Inc. $ANIP Stock Position Reduced by Kennedy Capital Management LLC
Kennedy Capital Management LLC cut its stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 28.7% during the third quarter, according to its most recent disclosure with the Securities...
MarketBeat·1d ago
News Placeholder
Beam Therapeutics Stock Surges 23% in 6 Months: What's Driving It?
BEAM shares jump 23% in six months as upbeat risto-cel data, pipeline expansion and new financing strengthen confidence in its gene-editing strategy.
Zacks·2d ago
<
1
2
...
>

Latest ANIP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.